Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kamada-API vs Marketed API in Alpha-1 Antitrypsin Deficiency
NCT00460096Phase 3Completed
- Sponsor
- Kamada Ltd.
- Start
- Mar 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of alpha1-proteinase inhibitor in alpha-1 antitrypsin deficiency (AATD), sponsored by Kamada Ltd.. Started Mar 2007; status: completed.
02
Drugs
alpha1-proteinase inhibitor
03
Conditions
alpha-1 antitrypsin deficiency (AATD)
Beyond the preview
Go deeper on NCT00460096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00460096.